Diverse galactooligosaccharides consumption by bifidobacteria: Implications of β-galactosidase-LacS operon

Bioscience, Biotechnology and Biochemistry

Volumn 79, Issue 4, 2015, Pages 664-672

  Akiyama, Takuya ^a   Kimura, Kazumasa ^b   Hatano, Hiroshi ^b  

^a Yakult Honsha European Research Center for Microbiology   (Belgium)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

Author keywords

Bifi dobacterium; Galactooligosaccharide; LacS

Indexed keywords

BIOLOGY;

ACID PRODUCTION; BIFI DOBACTERIUM; BIFIDOBACTERIUM ADOLESCENTIS; GALACTO-OLIGOSACCHARIDES; HEALTH BENEFITS; HUMAN INTESTINE; LACS; TRANSCRIPTION ANALYSIS;

BACTERIA;

BIFIDOBACTERIUM ADOLESCENTIS;

BETA GALACTOSIDASE; CARRIER PROTEIN; CULTURE MEDIUM; LACTOSE PERMEASE; OLIGOSACCHARIDE; PREBIOTIC AGENT;

ANAEROBIC GROWTH; BIFIDOBACTERIUM; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; OPERON;

ANAEROBIOSIS; BETA-GALACTOSIDASE; BIFIDOBACTERIUM; CULTURE MEDIA; GENE EXPRESSION REGULATION, BACTERIAL; MEMBRANE TRANSPORT PROTEINS; OLIGOSACCHARIDES; OPERON; PREBIOTICS; TRANSCRIPTION, GENETIC;

EID: 84927714708     PISSN: 09168451     EISSN: 13476947     Source Type: Journal    
DOI: 10.1080/09168451.2014.987204     Document Type: Article

References (35)

1. Eckburg PB, Bik EM, Bernstein CN, Purdom E, Dethlefsen L, Sargent M, Gill SR, Nelson KE, Relman DA. Diversity of the human intestinal microbial flora. Science. 2005;308:1635-1638.
2. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307:1920-1925.
3. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027-1031.
4. Cani PD, Osto M, Geurts L, Everard A. Involvement of gut microbiota in the development of low-grade inflammation and type 2 diabetes associated with obesity. Gut Microbes. 2012;3:279-288.
5. Ivanov II, Honda K. Intestinal commensal microbes as immune modulators. Cell Host Microbe. 2012;12:496-508.
6. Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J. Nutr. 1995;125:1401-1412.
7. Roberfroid M, Gibson GR, Hoyles L, McCartney AL, Rastall R, Rowland I, Wolvers D, Watzl B, Szajewska H, Stahl B, Guarner F, Respondek F, Whelan K, Coxam V, Davicco MJ, Leotoing L, Wittrant Y, Delzenne NM, Cani PD, Neyrinck AM, Meheust A. Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 2010;104:S1-S63.
8. Vulevic J, Juric A, Tzortzis G, Gibson GR. A mixture of transgalactooligosaccharides reduces markers of metabolic syndrome and modulates the fecal microbiota and immune function of overweight adults. J. Nutr. 2013;143:324-331.
9. Tannock GW, Munro K, Bibiloni R, Simon MA, Hargreaves P, Gopal P, Harmsen H, Welling G. Impact of consumption of oli-gosaccharide-containing biscuits on the fecal microbiota of humans. Appl. Environ. Microbiol. 2004;70:2129-2136.
10. Weaver CM, Martin BR, Nakatsu CH, Armstrong AP, Clavijo A, McCabe LD, McCabe GP, Duignan S, Schoterman MH, van den Heuvel EG. Galactooligosaccharides improve mineral absorption and bone properties in growing rats through gut fermentation. J. Agric. Food Chem. 2011;59:6501-6510.
11. Silk DB, Davis A, Vulevic J, Tzortzis G, Gibson GR. Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment. Pharmacol. Ther. 2009;29:508-518.
12. Davis LM, Martínez I, Walter J, Hutkins R. A dose dependent impact of prebiotic galactooligosaccharides on the intestinal microbiota of healthy adults. Int. J. Food Microbiol. 2010;144: 285-292.
13. Davis LM, Martínez I, Walter J, Goin C, Hutkins RW. Barcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humans. PLoS One. 2011;6:e25200.
14. Matsumoto K, Takada T, Yuki N, Kawakami K, Sakai T, Nomoto K, Kimura K, Matsumoto K, Iino H. Effects of transgalactosylated oligosaccharides mixture (N-GOS) on human intestinal microflora. J. Intest. Microbiol. 2004;18:25-35.
15. Kolida S, Gibson GR. Synbiotics in health and disease. Annu. Rev. Food Sci. Technol. 2011;2:373-393.
16. Kukkonen K, Savilahti E, Haahtela T, Juntunen-Backman K, Korpela R, Poussa T, Tuure T, Kuitunen M. Probiotics and prebiotic galacto-oligosaccharides in the prevention of allergic diseases: a randomized, double-blind, placebo-controlled trial. J. Allergy Clin. Immunol. 2007;119:192-198.
17. van Zanten GC, Knudsen A, Röytiö H, Forssten S, Lawther M, Blennow A, Lahtinen SJ, Jakobsen M, Svensson B, Jespersen L. The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon. PLoS One. 2012;7:e47212.
18. Ishikawa H, Matsumoto S, Ohashi Y, Imaoka A, Setoyama H, Umesaki Y, Tanaka R, Otani T. Beneficial effects of probiotic bifidobacterium and galacto-oligosaccharide in patients with ulcerative colitis: a randomized controlled study. Digestion. 2011;84:128-133.
19. Matsuki T, Watanabe K, Tanaka R, Fukuda M, Oyaizu H. Distribution of bifidobacterial species in human intestinal microflora examined with 16S rRNA-gene-targeted species-specific primers. Appl. Environ. Microbiol. 1999;65:4506-4512.
20. Wolin MJ, Zhang Y, Bank S, Yerry S, Miller TL. NMR detection of 13CH3 13COOH from 3-13C-glucose: a signature for Bifidobacterium fermentation in the intestinal tract. J. Nutr. 1998;128:91-96.
21. de Vries W, Stouthamer AH. Pathway of glucose fermentation in relation to the taxonomy of bifidobacteria. J. Bacteriol. 1967;93:574-576.
22. Scardovi V, Trovatelli LD. The fructose-6-phosphate shunt as a peculiar pattern of hexose degradation in the genus Bifidobacterium. Ann. Microbiol. 1965;15:19-29.
23. Amaretti A, Bernardi T, Tamburini E, Zanoni S, Lomma M, Matteuzzi D, Rossi M. Kinetics and metabolism of Bifidobacterium adolescentis MB 239 growing on glucose, galactose, lactose, and galactooligosaccharides. Appl. Environ. Microbiol. 2007;73:3637-3644.
24. Van der Meulen R, Adriany T, Verbrugghe K, De Vuyst L. Kinetic analysis of bifidobacterial metabolism reveals a minor role for succinic acid in the regeneration of NAD+ through its growth-associated production. Appl. Environ. Microbiol. 2006;72:5204-5210.
25. Jacob F, Monod J. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 1961;3:318-356.
26. Andersen JM, Barrangou R, Abou Hachem M, Lahtinen S, Goh YJ, Svensson B, Klaenhammer TR. Transcriptional and functional analysis of galactooligosaccharide uptake by lacS in Lactobacillus acidophilus. Proc. Nat. Acad. Sci. USA. 2011;108: 17785-17790.
27. Parche S, Amon J, Jankovic I, Rezzonico E, Beleut M, Barutcu H, Schendel I, Eddy MP, Burkovski A, Arigoni F, Titgemeyer F. Sugar transport systems of Bifidobacterium longum NCC2705. J. Mol. Microbiol. Biotechnol. 2007;12:9-19.
28. Sela DA. Bifidobacterial utilization of human milk oligosaccharides. Int. J. Food Microbiol. 2011;149:58-64.
29. Sonnenburg ED, Zheng H, Joglekar P, Higginbottom SK, Firbank SJ, Bolam DN, Sonnenburg JL. Specifi city of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell. 2010;141:1241-1252.
30. Sela DA, Prince NP, Mills DA. Metabolism of bifidobacteria. In: Mayo B, van Sinderen D, editors. Bifidobacteria: genomics and molecular aspects. Norfolk: Caister Academic Press; 2010. p. 45-70.
31. Fetsch EE, Davidson AL. Vanadate-catalyzed photocleavage of the signature motif of an ATP-binding cassette (ABC) transporter. Proc. Nat. Acad. Sci. USA. 2002;99:9685-9690.
32. Hinz SW, van den Broek LA, Beldman G, Vincken JP, Voragen AG. β-galactosidase from Bifidobacterium adolescentis DSM20083 prefers β(1,4)-galactosides over lactose. Appl. Microbiol. Biotechnol. 2004;66:276-284.
33. Asakuma S, Hatakeyama E, Urashima T, Yoshida E, Katayama T, Yamamoto K, Kumagai H, Ashida H, Hirose J, Kitaoka M. Physiology of consumption of human milk oligosaccharides by infant gut-associated bifidobacteria. J. Biol. Chem. 2011;286: 34583-34592.
34. Barboza M, Sela DA, Pirim C, Locascio RG, Freeman SL, German JB, Mills DA, Lebrilla CB. Glycoprofiling bifidobacterial consumption of galacto-oligosaccharides by mass spectrometry reveals strain-specifi c, preferential consumption of glycans. Appl. Environ. Microbiol. 2009;75:7319-7325.
35. Saier MH, Jr. A functional-phylogenetic classification system for transmembrane solute transporters. Microbiol. Mol. Biol. Rev. 2000;64:354-411.